Award: Boehringer Ingelheim is Global Top Employer 2022
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
INGELHEIM, Germany -- Businesswire -- The Top Employers Institute awarded Boehringer Ingelheim for the second year in succession a “Global Top Employer”, one of the world’s eleven best employers. The award shows that the research-driven pharmaceutical company is strongly oriented to the needs and well-being of its employees. Boehringer Ingelheim has been listed among the top employers in many countries and regions for the past eight years. This year, Boehringer Ingelheim will receive the award in 29 countries, as well as in Europe and the Latin America, and Asia-Pacific regions. The independent Top Employers Institute certifies employers worldwide who wish to offer their employees excellent working conditions and support their development. Certification is based on a multi-level program to examine human resources management with detailed final feedback.
Boehringer Ingelheim continued to thrive in the area of employee engagement where it particularly stands out with regards to rewards and recognition, compared to its competitors. The Top Employers Institute also highlighted the agile work environment as well as the company’s values, ethics and integrity that result in the strong, inclusive corporate culture.
“The human dimension is a central part of Boehringer Ingelheim. This includes the feeling of belonging and an ongoing attention on everyone’s wellbeing at work. The certification as Global Top Employer recognizes once again that our work environment makes the company stand out as an employer”, says Dr Sven Sommerlatte, Global Head of Human Resources at Boehringer Ingelheim. “We are committed to empowering all people and foster diverse teams that deliver inclusive solutions. This forms the basis for our corporate innovation culture.”
An example of employee orientation is the well-established mobile working. It helps, among other, to ensure that during the COVID pandemic, employees are empowered to actively adapt their work to health protection requirements and to ensure business continuity. This also applies for virtual onboarding processes for which the company established concepts for new employees working from home. Another point highlighted by the jury refers to the ethical, inclusive approach to corporate decisions and a clear focus on the transfer and application of company values. The family business also takes care of individual development opportunities through tailor-made education and training programs throughout the employee’s working life.
As a research-driven pharmaceutical company, Boehringer Ingelheim is committed to create value in areas of unmet medical need and engage with communities and society to change lives for the better. This has recently been exemplified through the extension of Boehringer Ingelheim’s initiative Making More Health (MMH) called “Boehringer Ingelheim Social Engagements” with a funding of EUR 50 million.
Intended audiences:
This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.
Please click on the following link for ‘Notes to Editors’:
https://www.boehringer-ingelheim.com/about-us/corporate-profile/award-boehringer-ingelheim-global-top-employer-2022
View source version on businesswire.com: https://www.businesswire.com/news/home/20220119006191/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Boehringer Ingelheim
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 삼성전자, 케이뱅크와 손잡고 ‘세상 편한 AI 라이프 챌린지박스’ 선보여 - 뉴스와이어
- 투썸플레이스, 비비와 함께한 ‘아박’ 광고 조회수 1000만 뷰 돌파 - 뉴스와이어
- 예술시장 진입을 위한 역량 강화 프로그램 ‘2024 청년예술가 역량강화 교육 기·성악 부문’ 참
- 아로마티카, 국내 뷰티 브랜드 최초 SBTi 승인 획득 - 뉴스와이어
- 압타머사이언스, 혈액 기반 폐암진단키트 인도시장 진출 위한 MOU 체결 - 뉴스와이어
- 동구바이오제약, 세계 최초 조루 복합제 ‘구세정’ 출시 예정 - 뉴스와이어
- LIG넥스원, 합동군사대와 ‘미래 국방 군사전문가 육성 MOU’ 체결 - 뉴스와이어
- RWS 코리아, 최첨단 AI 탑재 번역툴 ‘트라도스 스튜디오 2024’ 출시 - 뉴스와이어
- LS일렉트릭-유니슨, 국산 풍력발전 기술경쟁력 강화 맞손 - 뉴스와이어
- 동원산업, 30g씩 소포장해 편의성 높인 ‘짜먹는 간편 명란’ 출시 - 뉴스와이어